Cannabinoids and gastrointestinal motility: pharmacology, clinical effects, and potential therapeutics in humans

M Camilleri - Neurogastroenterology & Motility, 2018 - Wiley Online Library
Background Cannabinoid agents and cannabis are frequently used for relief of diverse
gastrointestinal symptoms. Purpose The objective of this article is to increase the awareness …

[PDF][PDF] Cannabinoids and gastrointestinal motility: animal and human studies.

G Aviello, B Romano, AA Izzo - European Review for Medical & …, 2008 - Citeseer
The plant Cannabis has been known for centuries to be beneficial in a variety of
gastrointestinal diseases, including emesis, diarrhea, inflammatory bowel disease and …

Cannabinoids and the gastrointestinal tract

M Camilleri, T Zheng - Clinical Gastroenterology and Hepatology, 2023 - Elsevier
The synthesis and degradation of endocannabinoids, location of cannabinoid (CB)
receptors, and cannabinoid mechanisms of action on immune/inflammatory, neuromuscular …

The gastrointestinal pharmacology of cannabinoids

AA Izzo, N Mascolo, F Capasso - Current opinion in pharmacology, 2001 - Elsevier
The digestive tract contains endogenous cannabinoids (anandamide and 2-
arachidonylglycerol) and cannabinoid CB1 receptors can be found on myenteric and …

Gut feelings about the endocannabinoid system

V Di Marzo, F Piscitelli - Neurogastroenterology & Motility, 2011 - Wiley Online Library
Stemming from the centuries‐old and well known effects of Cannabis on intestinal motility
and secretion, research on the role of the endocannabinoid system in gut function and …

Cannabinoids and the gut: new developments and emerging concepts

AA Izzo, KA Sharkey - Pharmacology & therapeutics, 2010 - Elsevier
Cannabis has been used to treat gastrointestinal (GI) conditions that range from enteric
infections and inflammatory conditions to disorders of motility, emesis and abdominal pain …

Cannabinoids for gastrointestinal diseases: potential therapeutic applications

GD Carlo, AA Izzo - Expert opinion on investigational drugs, 2003 - Taylor & Francis
Δ9-Tetrahydrocannabinol (the active ingredient of marijuana), as well as endogenous and
synthetic cannabinoids, exert many biological functions by activating two types of …

Role of cannabinoid receptors in the control of gastrointestinal motility and perception

J Fioramonti, L Bueno - Expert review of gastroenterology & …, 2008 - Taylor & Francis
The identification of endocannabinoids and cannabinoid CB1 receptors in key areas of the
intestinal wall, such as cholinergic neurons, supports a role for cannabinoids in the control of …

Cannabinoid pharmacology and therapy in gut disorders

JA Uranga, G Vera, R Abalo - Biochemical Pharmacology, 2018 - Elsevier
Cannabis sp. and their products (marijuana, hashish…), in addition to their recreational,
industrial and other uses, have a long history for their use as a remedy for symptoms related …

The role of cannabinoids in regulation of nausea and vomiting, and visceral pain

Z Malik, D Baik, R Schey - Current Gastroenterology Reports, 2015 - Springer
Marijuana derived from the plant Cannabis sativa has been used for the treatment of many
gastrointestinal (GI) disorders, including anorexia, emesis, abdominal pain, diarrhea, and …